AlphaGrep UK Ltd’s Halozyme HALO Stock Holding History

AlphaGrep UK Ltd’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,128	Closed	-$211K	–	851
2025 Q4	$211K	Buy	+3,128	New	+$210K	0.07%	609

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AlphaGrep UK Ltd's HALO Position: Q1 2026 in Review

AlphaGrep UK Ltd sold out of Halozyme (HALO) in Q1 2026, closing a stake of 3,128 shares — an estimated $211K sold.

AlphaGrep UK Ltd first reported a position in HALO in Q4 2025 and held it in 1 quarter. The position peaked at $211K in Q4 2025. 635 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

AlphaGrep UK Ltd reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
AlphaGrep UK Ltd sold 3,128 Halozyme shares in Q1 2026, an estimated $211K.
AlphaGrep UK Ltd first reported a position in Halozyme in Q4 2025 and held it in 1 quarter.
AlphaGrep UK Ltd's Halozyme position peaked at $211K in Q4 2025.
635 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.